The findings showed that AK5 was strongly expressed in the majority of malignancies, including head and neck squamous cell carcinoma (HNSC) and cholangiocarcinoma (CHOL) (Figure 8a). This evidence concerns the gene AK5 and head and neck squamous cell carcinoma.